Jump to content

Galderma Patent for Brimonidine Foam


Recommended Posts

  • Root Admin


Galderma has applied for a brimonidine foam patent which according to the patent is claimed to have the "advantage of remaining on the surface of the skin and of delivering a smaller amount so as to prevent undesirable effects (rebound effect) and too obtain a foam that is suitable for treating rosacea."


Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Create New...

Important Information

Terms of Use